|
|
Article: Challenge may be to R&D staff, not just QA/QC, says Mallinckrodt exec.(PAT)
- Article from:
- Validation Times
- Article date:
- October 1, 2003
- Author:
CopyrightCOPYRIGHT 2003 Washington Information Source, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PHILADELPHIA -- FDA has been trying to get the pharmaceutical industry to implement PAT as a means of applying real-time QA/QC instead of testing and validating batches after the fact, but the real challenge to PAT acceptance might not just be with QA and QC staff, but R&D personnel.
So says Vishal Gupta, Ph.D., a senior research investigator at Tyco Healthcare Mallinckrodt in St. Louis, who told CPT's conference here Oct. 1:
"It's going to be a big learning phase for all of us, understanding how exactly R&D can apply PAT, and it will be important that everybody is on the same page."
Gupta pointed to PAT's potential for anticipating future ...